(Q37938311)

25 August 2017

1 reference

title

New cytotoxic drugs in treatment of breast cancer (English)

1 reference

25 August 2017

0 references

Mouridsen HT

1

1 reference

25 August 2017

publication date

1 January 1990

1 reference

25 August 2017

1 reference

25 August 2017

volume

29

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

343-347

1 reference

Carminomycin versus doxorubicin in advanced breast cancer, a randomized phase II study of the E.O.R.T.C. Breast Cancer Cooperative Group

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

Oral idarubicin in the treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

A phase II study of oral weekly 4-demethoxydaunorubicin in advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

Phase II trial with oral idarubicin in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

Epirubicin treatment of advanced breast carcinoma with the weekly low-dose regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

Effective palliation of advanced breast cancer with weekly low dose epirubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

A comparison of mitoxantrone and doxorubicin in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer. A preliminary report of a controlled clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869009090012

10.3109/02841869009090012

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference